vs

Side-by-side financial comparison of FONAR CORP (FONR) and TRUSTCO BANK CORP N Y (TRST). Click either name above to swap in a different company.

TRUSTCO BANK CORP N Y is the larger business by last-quarter revenue ($49.5M vs $25.5M, roughly 1.9× FONAR CORP). TRUSTCO BANK CORP N Y runs the higher net margin — 32.9% vs 8.0%, a 24.8% gap on every dollar of revenue. Over the past eight quarters, TRUSTCO BANK CORP N Y's revenue compounded faster (6.8% CAGR vs -0.3%).

FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.

TRUSTCO BANK CORP N Y is a regional U.S. financial holding company that provides a full suite of retail and commercial banking products and services, including personal deposit accounts, mortgage loans, small business financing, and wealth management solutions. It primarily operates across New York, Florida, and several other U.S. states, serving individual consumers and small business client segments.

FONR vs TRST — Head-to-Head

Bigger by revenue
TRST
TRST
1.9× larger
TRST
$49.5M
$25.5M
FONR
Higher net margin
TRST
TRST
24.8% more per $
TRST
32.9%
8.0%
FONR
Faster 2-yr revenue CAGR
TRST
TRST
Annualised
TRST
6.8%
-0.3%
FONR

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
FONR
FONR
TRST
TRST
Revenue
$25.5M
$49.5M
Net Profit
$2.1M
$16.3M
Gross Margin
Operating Margin
13.5%
Net Margin
8.0%
32.9%
Revenue YoY
2.4%
Net Profit YoY
4.7%
14.1%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FONR
FONR
TRST
TRST
Q1 26
$49.5M
Q4 25
$25.5M
$48.2M
Q3 25
$26.0M
$47.8M
Q2 25
$27.3M
$46.6M
Q1 25
$27.2M
$45.3M
Q4 24
$24.9M
$43.3M
Q3 24
$25.0M
$43.6M
Q2 24
$25.9M
$43.4M
Net Profit
FONR
FONR
TRST
TRST
Q1 26
$16.3M
Q4 25
$2.1M
$15.6M
Q3 25
$2.3M
$16.3M
Q2 25
$729.3K
$15.0M
Q1 25
$2.5M
$14.3M
Q4 24
$2.0M
$11.3M
Q3 24
$3.1M
$12.9M
Q2 24
$830.4K
$12.6M
Operating Margin
FONR
FONR
TRST
TRST
Q1 26
Q4 25
13.5%
43.7%
Q3 25
14.1%
44.6%
Q2 25
5.3%
42.3%
Q1 25
15.2%
41.3%
Q4 24
11.9%
34.0%
Q3 24
21.0%
38.8%
Q2 24
7.4%
37.9%
Net Margin
FONR
FONR
TRST
TRST
Q1 26
32.9%
Q4 25
8.0%
32.3%
Q3 25
8.7%
34.0%
Q2 25
2.7%
32.3%
Q1 25
9.2%
31.5%
Q4 24
7.9%
26.0%
Q3 24
12.6%
29.5%
Q2 24
3.2%
28.9%
EPS (diluted)
FONR
FONR
TRST
TRST
Q1 26
Q4 25
$0.85
Q3 25
$0.86
Q2 25
$0.79
Q1 25
$0.75
Q4 24
$0.59
Q3 24
$0.68
Q2 24
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FONR
FONR
TRST
TRST
Cash + ST InvestmentsLiquidity on hand
$121.0K
Total DebtLower is stronger
$112.9M
Stockholders' EquityBook value
$176.9M
$670.9M
Total Assets
$217.2M
$6.5B
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FONR
FONR
TRST
TRST
Q1 26
Q4 25
$121.0K
$730.4M
Q3 25
$122.0K
$695.6M
Q2 25
$56.5M
$713.6M
Q1 25
$123.0K
$756.1M
Q4 24
$121.0K
$641.8M
Q3 24
$136.0K
$523.0M
Q2 24
$56.5M
$536.1M
Total Debt
FONR
FONR
TRST
TRST
Q1 26
$112.9M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$66.9K
Stockholders' Equity
FONR
FONR
TRST
TRST
Q1 26
$670.9M
Q4 25
$176.9M
$686.6M
Q3 25
$174.9M
$692.0M
Q2 25
$172.6M
$692.8M
Q1 25
$171.9M
$687.8M
Q4 24
$169.8M
$676.3M
Q3 24
$168.7M
$669.0M
Q2 24
$166.0M
$655.2M
Total Assets
FONR
FONR
TRST
TRST
Q1 26
$6.5B
Q4 25
$217.2M
$6.4B
Q3 25
$218.4M
$6.3B
Q2 25
$216.9M
$6.3B
Q1 25
$214.9M
$6.3B
Q4 24
$208.0M
$6.2B
Q3 24
$212.3M
$6.1B
Q2 24
$214.2M
$6.1B
Debt / Equity
FONR
FONR
TRST
TRST
Q1 26
0.17×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FONR
FONR
TRST
TRST
Operating Cash FlowLast quarter
$171.0K
Free Cash FlowOCF − Capex
$-227.0K
FCF MarginFCF / Revenue
-0.9%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
0.08×
TTM Free Cash FlowTrailing 4 quarters
$5.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FONR
FONR
TRST
TRST
Q1 26
Q4 25
$171.0K
$57.6M
Q3 25
$1.7M
$12.8M
Q2 25
$4.2M
$27.1M
Q1 25
$3.1M
$1.3M
Q4 24
$2.2M
$59.4M
Q3 24
$1.7M
$16.5M
Q2 24
$4.6M
$18.7M
Free Cash Flow
FONR
FONR
TRST
TRST
Q1 26
Q4 25
$-227.0K
$45.7M
Q3 25
$-177.0K
$10.0M
Q2 25
$3.6M
$24.9M
Q1 25
$2.6M
$-3.3M
Q4 24
$1.5M
$54.6M
Q3 24
$-148.0K
$15.6M
Q2 24
$4.2M
$17.6M
FCF Margin
FONR
FONR
TRST
TRST
Q1 26
Q4 25
-0.9%
95.0%
Q3 25
-0.7%
20.9%
Q2 25
13.1%
53.5%
Q1 25
9.4%
-7.2%
Q4 24
6.0%
126.0%
Q3 24
-0.6%
35.7%
Q2 24
16.1%
40.5%
Capex Intensity
FONR
FONR
TRST
TRST
Q1 26
Q4 25
1.6%
24.6%
Q3 25
7.2%
5.9%
Q2 25
2.4%
4.5%
Q1 25
2.2%
10.0%
Q4 24
3.0%
11.3%
Q3 24
7.2%
2.1%
Q2 24
1.6%
2.6%
Cash Conversion
FONR
FONR
TRST
TRST
Q1 26
Q4 25
0.08×
3.70×
Q3 25
0.75×
0.79×
Q2 25
5.79×
1.80×
Q1 25
1.26×
0.09×
Q4 24
1.14×
5.27×
Q3 24
0.53×
1.28×
Q2 24
5.54×
1.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FONR
FONR

Managementof Diagnostic Imaging Centers$23.2M91%
Manufacturingand Servicingof Medical Equipment$2.4M9%

TRST
TRST

Net Interest Income$44.7M90%
Noninterest Income$4.8M10%

Related Comparisons